Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Dickson Kofi Wiredu Ocansey · Sankore

Dickson Kofi Wiredu Ocansey

ORCID, self-asserted

ORCID 0000-0003-3547-0857

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

26

Citations

1,006

h-index

19

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

22

Affiliations

Every institution this scholar has appeared with on a work, by how many.

University of Cape Coast26 works
Ghana Health Service1 works

Publications

26 works in the graph, newest first.

Lactobacillus helveticus R0052-derived membrane vesicles ameliorate DSS-induced inflammatory bowel disease by modulating the gut microbiota and activating the cholinergic anti-inflammatory pathway
2026International ImmunopharmacologyJournal4 citations10.1016/j.intimp.2025.116058
Patterns of early-life microbial exposure and infection risk in hospital-born neonates in a tertiary hospital setting in Ghana
2026BMC MicrobiologyJournalOpen accessSenior authorCorresponding0 citations10.1186/s12866-026-05330-y
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy
2025Autoimmunity ReviewsJournal4 citations10.1016/j.autrev.2025.103861
The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment
2024International Journal of NanomedicineJournalOpen access74 citations10.2147/ijn.s471360
Intestinal mucus barrier: A potential therapeutic target for IBD
2024Autoimmunity Reviews

Journal

71 citations

10.1016/j.autrev.2024.103717

hucMSC-Ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization via the METTL3-Slc37a2-YTHDF1 axis

2024Cell Biology and ToxicologyJournalOpen access34 citations10.1007/s10565-024-09921-1

Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease

2024Gut MicrobesJournalOpen access30 citations10.1080/19490976.2024.2341670

Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease

2024PharmaceuticalsJournalOpen access26 citations10.3390/ph17050607

The Function of Necroptosis and Its Treatment Target in IBD

2024Mediators of InflammationJournalOpen access21 citations10.1155/2024/7275309

Current evidence and therapeutic implication of PANoptosis in cancer

2023TheranosticsJournalOpen accessFirst author104 citations10.7150/thno.91814

The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease

2023Gut MicrobesJournalOpen accessFirst author74 citations10.1080/19490976.2023.2176118

The effect of students’ online learning experience on their satisfaction during the COVID-19 pandemic: The mediating role of preference

2023Frontiers in PsychologyJournalOpen accessSenior author44 citations10.3389/fpsyg.2023.1095073

Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer

2023Frontiers in EndocrinologyJournalOpen access40 citations10.3389/fendo.2023.1242991

The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases

2023Frontiers in ImmunologyJournalOpen access19 citations10.3389/fimmu.2023.1166536

Exosome-mediated macrophage regulation for inflammatory bowel disease repair: a potential target of gut inflammation.

2023PubMedJournalOpen access7 citations

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy

2022Frontiers in ImmunologyJournalOpen access105 citations10.3389/fimmu.2022.835005

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease

2022Gut PathogensJournalOpen access64 citations10.1186/s13099-022-00499-9

HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis

2022International ImmunopharmacologyJournal56 citations10.1016/j.intimp.2022.108925

Mesenchymal stem cell-derived exosome mitigates colitis via the modulation of the gut metagenomics–metabolomics–farnesoid X receptor axis

2022Biomaterials ScienceJournalFirst author48 citations10.1039/d2bm00559j

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer

2022Frontiers in PharmacologyJournalOpen access45 citations10.3389/fphar.2022.1016836

Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p/VEGFR3/AKT axis to ameliorate inflammatory bowel disease

2022International ImmunopharmacologyJournal38 citations10.1016/j.intimp.2022.109066

The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease

2022International ImmunopharmacologyJournalOpen access34 citations10.1016/j.intimp.2022.109466

hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis

2022Molecular PharmaceuticsJournal26 citations10.1021/acs.molpharmaceut.1c00450

Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers

2022Frontiers in Bioengineering and BiotechnologyJournalOpen access12 citations10.3389/fbioe.2022.1019459

HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated miR3202/HOXB13 pathway

2022Journal of Zhejiang University SCIENCE BJournalOpen access15 citations10.1631/jzus.b2100793

Research on natural products from traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury.

2022PubMedJournalOpen access11 citations